PREPOPIK
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $1.5M | 580 | 413 |
| 2017 | $4.7M | 6,767 | 2,687 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5.9M | 223 | 95.9% |
| Food and Beverage | $112,057 | 6,996 | 1.8% |
| Consulting Fee | $90,604 | 25 | 1.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,180 | 14 | 0.5% |
| Travel and Lodging | $19,658 | 61 | 0.3% |
| Education | $132.64 | 28 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Randomized, Assessor-Blinded, Multi-Center Study Investigating the Efficacy, Safety, and Tolerability of Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution versus Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Powder for Oral Solution PREPOPIK for Colon Cleansing in Preparation for Colonoscopy | Ferring International Pharmascience Center US | $4.8M | 0 |
| BLI4700-302 | Braintree Laboratories, Inc. | $964,095 | 0 |
| A Randomized, Assessor-Blind, Multicenter, Dose-Ranging Study Comparing the Safety and Efficacy of Prepopik Versus Polyethylene Glycol Preparation Local Standard of Care in Children Aged 9 Years to 16 Years | Ferring International Pharmascience Center US | $92,247 | 0 |
| Randomized Comparison of the Impact of Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid versus Polyethylene Glycol Bowel Preparation on Inpatient Colonoscopy Quality Parameters | Ferring Pharmaceuticals Inc. | $61,012 | 0 |
| A Randomized, Assessor-Blind, Multicenter, Dose-Ranging Study Comparing the Safety and Efficacy of Prepopik versus Polyethylene Glycol Preparation Local Standard of Care in Children Aged 9 Years to 16 years | Ferring International Pharmascience Center US | $20,583 | 0 |
Top Doctors Receiving Payments for PREPOPIK — Page 5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Gastroenterology | Las Vegas, NV | $143.05 | 20 |
| , MD | Gastroenterology | Houston, TX | $142.95 | 8 |
| , M.D | Gastroenterology | Chicago, IL | $142.68 | 9 |
| , M.D | Gastroenterology | Great Neck, NY | $142.60 | 11 |
| , M.D | Gastroenterology | Bronx, NY | $141.38 | 12 |
| , MD | Gastroenterology | Huntington Station, NY | $140.67 | 6 |
| , M.D | Gastroenterology | Oklahoma City, OK | $140.55 | 10 |
| , DO | Gastroenterology | South Bend, IN | $139.37 | 6 |
| , MD | Gastroenterology | New York, NY | $138.82 | 7 |
| , M.D | Gastroenterology | New York, NY | $138.82 | 7 |
| , M.D | Gastroenterology | New York, NY | $137.20 | 8 |
| , MD | Colon & Rectal Surgery | Columbus, OH | $135.97 | 11 |
| , M.D | Gastroenterology | Kansas City, MO | $135.41 | 8 |
| , M.D | Internal Medicine | Highland, CA | $135.33 | 12 |
| , M.D | Specialist | New York, NY | $134.30 | 8 |
| , M.D | Internal Medicine | Baton Rouge, LA | $133.69 | 11 |
| , M.D | Gastroenterology | East Boston, MA | $133.21 | 20 |
| , MD | Gastroenterology | New York, NY | $132.95 | 7 |
| , M.D | Internal Medicine | Garden City, NY | $132.73 | 8 |
| , M.D | Gastroenterology | West Palm Beach, FL | $132.39 | 11 |
| , MD | Internal Medicine | New York, NY | $131.36 | 10 |
| , MD | Gastroenterology | Malverne, NY | $130.95 | 3 |
| , MD | Gastroenterology | Lake Worth, FL | $130.92 | 7 |
| , MD | Gastroenterology | Great Neck, NY | $130.66 | 13 |
| , MD | Gastroenterology | Great Neck, NY | $130.66 | 13 |
Manufacturing Companies
- Ferring International Pharmascience Center US $4.9M
- Braintree Laboratories, Inc. $964,095
- Ferring Pharmaceuticals Inc. $313,643
Product Information
- Type Drug
- Total Payments $6.2M
- Total Doctors 2,768
- Transactions 7,347
About PREPOPIK
PREPOPIK is a drug associated with $6.2M in payments to 2,768 healthcare providers, recorded across 7,347 transactions in the CMS Open Payments database. The primary manufacturer is Ferring International Pharmascience Center US.
Payment data is available from 2017 to 2018. In 2018, $1.5M was paid across 580 transactions to 413 doctors.
The most common payment nature for PREPOPIK is "Unspecified" ($5.9M, 95.9% of total).
PREPOPIK is associated with 5 research studies, including "A Randomized, Assessor-Blinded, Multi-Center Study Investigating the Efficacy, Safety, and Tolerability of Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution versus Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Powder for Oral Solution PREPOPIK for Colon Cleansing in Preparation for Colonoscopy" ($4.8M).